may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
he let it ring and ring. "aren't you going to answer it?" his wife asked. "no, i know what's on the other line," olczyk said..